Skip to main content
eLife logoLink to eLife
. 2015 Jun 8;4:e09169. doi: 10.7554/eLife.09169

Correction: Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs

Irawati Kandela, James Chou, Kartoa Chow; Reproducibility Project: Cancer Biology
PMCID: PMC4458839  PMID: 26052861

Kandela I, Chou J, Chow K, Reproducability Project: Cancer Biology. 2015. Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. eLife 4:e06959. doi: 10.7554/eLife.06959

Published 22 May 2015

In the published Registered report there was an error in the iRDG peptide sequence listed in ‘Protocol 1: synthesis of iRDG’. The sequence was incorrectly listed as H-Gly-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys-NH2. The correct sequence is: H-Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys-NH2.

This article has been corrected accordingly.

Competing interests

RP:CB: We disclose that EI, FT, JL, and NP are employed by and hold shares in Science Exchange Inc. The experiments presented in this manuscript will be conducted by IK at the Developmental Therapeutics Core and JC at Lifetein, which are Science Exchange labs.

The other authors declare that no competing interests exist.


Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

RESOURCES